Blocked From Promoting Off-Model Ozempic, Telehealth Startups Embrace a Much less Efficient Drug

After telehealth startups just lately misplaced the flexibility to promote actual copies of patented GLP-1 weight-loss…

Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating Warfare on Knockoff Medicine

The FDA gave compounders a grace interval to wind down their manufacturing of the medication after…